medigraphic.com
ISSN 0185-3252 (Impreso)
Revista de la Asociación Médica del Centro Médico ABC

2015, Número 4

<< Anterior Siguiente >>

An Med Asoc Med Hosp ABC 2015; 60 (4)


Manifestaciones gastrointestinales en niños con trastorno de espectro autista

Casaubon GPR, Goldbard RD

Idioma: Español
Referencias bibliográficas: 31
Paginas: 266-272
Archivo PDF: 217.01 Kb.


RESUMEN

Introducción: El trastorno del espectro autista es un grupo de discapacidades del desarrollo que pueden causar impactos significativos sociales, de comunicación, y problemas de comportamiento. Se reporta una prevalencia del 1% de la población. Se sabe que es el resultado de una alteración durante el desarrollo cerebral, así como de una interacción compleja entre riesgo genético y exposición ambiental. Objetivo: Dado que hay una mayor incidencia del TEA a nivel mundial, el pediatra debe conocer la patología gastrointestinal frecuente en ellos y buscarla de forma intencionada. Las manifestaciones gastrointestinales más frecuentes reportadas en diversas series son flatulencias (60%), distensión (37%) y dolor abdominal (37%). Conclusiones: El conocer los trastornos gastrointestinales más frecuentes en este grupo de pacientes permite un tratamiento adecuado y oportuno, que mejora frecuentemente la intensidad de los trastornos conductuales de algunos de estos pacientes.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders: autism and developmental disabilities monitoring network. United States; 2008. [Fecha de consulta: diciembre 2014]. Available in: www.cdc.gov/ncbddd/autism/documents/ADDM-2012-Community-Report.pdf

  2. Rosenblatt AI, Carbone PS, Winnie Y. Expert guidance from the American Academy of Pediatrics. Autism Spectrum Disorders: What every parent needs to know. Illinois: American Academy of Pediatrics; 2013.

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.

  4. DiGuiseppi C, Hepburn S, Davis JM, Fidler DJ, Hartway S, Lee NR et al. Screening for autism spectrum disorders in children with Down syndrome. J Dev Behav Pediatr. 2010; 31: 181-191.

  5. Cohen D, Pichard N, Tordjman S, Baumann C, Burglen L, Excoffier E et al. Specific genetic disorders and autism: clinical contribution towards their identification. J Autism Dev Disord. 2005; 35 (1): 103-116.

  6. Hall SS, Lightbody AA, Reiss AL. Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome. Am J Ment Retard. 2008; 113 (1): 44-53.

  7. Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, Law PA. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med. 2009; 163 (10): 907-914.

  8. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011; 68 (11): 1095-1102.

  9. Ronald A, Happe F, Bolton P, Butcher LM, Price TS, Wheelwright S et al. Genetic heterogeneity between the three components of the autism spectrum: A twin study. J Am Acad Child Adolesc Psychiatry. 2006; 45 (6): 691-699.

  10. Taniai H, Nishiyama T, Miyahci T, Imaeda M, Sumi S. Genetic influences on the broad spectrum of autism: study of proband-ascertained twins. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B (6): 844-849.

  11. Ozonoff S, Young GS, Carter A, Messinger D, Yirmiya N, Zwaigenbaum L et al. Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics. 2011; 128: e488-e495.

  12. Sumi S, Taniai H, Miyachi T, Tanemura M. Sibling risk of pervasive developmental disorder estimated by means of an epidemiologic survey in Nagoya, Japan. J Hum Genet. 2006; 51: 518-522.

  13. Horvath K, Papadimitriou J, Rabsztyn A, Drachenberg C, Tildon JT. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr. 1999; 135 (5): 559-563.

  14. Horvath K, Perman J. Autistic disorder and gastrointestinal disease. Curr Opin Pediatr. 2002; 14: 583-587.

  15. McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics. 2014; 133: 872-883.

  16. Levy S, Hyman S. Complementary and alternative medicine treatments for children with autism spectrum disorder. Child Adolesc Psychiatr Clin N Am. 2008; 17 (4): 801-816.

  17. Zecavati N, Spence SJ. Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr Neurol Neurosci Rep. 2009; 9 (2): 129-136.

  18. Buie T, Fuchs GJ 3rd, Furuta GT, Kooros K, Levy J, Lewis JD et al. Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs. Pediatrics. 2010; 125: S19-S29.

  19. De Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010; 51 (4): 418-424.

  20. Wakefield AJ. The gut-brain axis in childhood developmental disorder. JPGN. 2002; 34: S14-S17.

  21. Indrio F, Riezzo G, Raimondi F, Di Mauro A, Francavilla R. Microbiota involvement in the gut-brain axis. JPGN. 2013; 57 (1): S11-S14.

  22. Foster JA, McVey-Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013; 36 (5): 305-312.

  23. Williams BL, Hornig M, Buie T, Bauman ML, Cho-Paik M, Wick I et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One. 2011; 6 (9): e24585.

  24. Williams BL, Hornig M, Parekh T, Lipkin WI. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio. 2012; 3 (1): e00261-11.

  25. MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 2007; 176: 149-169.

  26. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci. 2011; 108: 16050-16055.

  27. Terrin G, Passariello A, Berni-Canani B. Drugs and tight junctions: adverse effects and opportunities for new therapeutic approaches. JPGN. 2012; 54 (2): 444-445.

  28. Piche T. Tight junctions and IBS-the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil. 2014; 26 (3): 296-302.

  29. Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013; 70 (4): 631-659.

  30. Jauregi A, Fernandez N, Irastorza I, Plaza-Izurieta L, Victoria JC, Bilbao JR. Alteration of tight junction gene expression in celiac disease. JPGN. 2014; 58 (6): 762-767.

  31. Högberg N, Stenbäck A, Carlsson PO, Wanders A, Lilja HE. Genes regulating tight junctions and cell adhesion are altered in early experimental necrotizing enterocolitis. J Pediatr Surg. 2013; 48: 2308-2312.




2020     |     www.medigraphic.com